These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6079790)

  • 21. Inhibition of pituitary-induced nodular hyperplasia in mammary glands of C3H mice fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    J Natl Cancer Inst; 1971 May; 46(5):929-39. PubMed ID: 4333726
    [No Abstract]   [Full Text] [Related]  

  • 22. The incidence of cancer in quantitatively transplanted mammary glands and its relation to age and milk agent of the donor and host mice.
    Hoshino K; Gardner WU; Pawlikowski RA
    Cancer Res; 1965 Nov; 25(10):1792-803. PubMed ID: 4285689
    [No Abstract]   [Full Text] [Related]  

  • 23. Serial transplantation of methylcholanthrene-treated mammary nodule outgrowth line D1.
    Medina D
    J Natl Cancer Inst; 1972 May; 48(5):1363-70. PubMed ID: 5030953
    [No Abstract]   [Full Text] [Related]  

  • 24. Mammary carcinogenesis in (C3H X RIII) F1 mice under different experimental conditions.
    Guggiari M; Rudali G
    Biomedicine; 1977 Jan; 27(1):27-31. PubMed ID: 851565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on preneoplastic lesions of mammary tumor in mice. 3. Strain difference in mammary gland response to hormonal stimulation, of high and low mammary tumor strains.
    Sakakura T
    Mie Med J; 1965 May; 15(1):15-25. PubMed ID: 5868548
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of prolactin in experimental breast cancer. 1].
    Nagasawa H
    Horumon To Rinsho; 1971 Aug; 19(8):625-9. PubMed ID: 4938502
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of pituitary isografts on the concentration of estrogen and glucocorticoid receptors in C3H mice mammary tumors.
    Coezy E; Rochefort H
    Eur J Cancer (1965); 1979 Oct; 15(10):1185-9. PubMed ID: 520392
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (10275-S).
    Matsuzawa A; Yamamoto T
    Cancer Res; 1976 May; 36(5):1598-606. PubMed ID: 178425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological and morphological characteristics of mammary tumors in GR mice.
    van Nie R; Dux A
    J Natl Cancer Inst; 1971 Apr; 46(4):885-97. PubMed ID: 5573773
    [No Abstract]   [Full Text] [Related]  

  • 30. Interactions between prolactin and ovarian secretions during mammary tumorigenesis in the mouse.
    Edery M; Goussard J; Vives C; Rudali G; Drosdowsky MA
    Biomedicine; 1980 Dec; 33(8):265-7. PubMed ID: 7213925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodule bioassay of the mouse mammary tumor virus: modifications and quantitative considerations.
    Nandi S; Haslam S; Helmich C; Ritter RI
    J Natl Cancer Inst; 1971 Jun; 46(6):1309-15. PubMed ID: 4325935
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Welsch CW; Clemens JA; Meites J
    J Natl Cancer Inst; 1968 Aug; 41(2):465-71. PubMed ID: 5671287
    [No Abstract]   [Full Text] [Related]  

  • 33. The developmental, noduligenic, and tumorigenic potentials of transplanted mammary glands and primary ducts from C3H mice previously fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    Cancer Res; 1972 Jan; 32(1):57-60. PubMed ID: 5007688
    [No Abstract]   [Full Text] [Related]  

  • 34. LACTOGENIC ACTION OF OVARIAN AND FRACTIONAL OR MULTIPLE PITUITARY ISOGRAFTS IN THE MOUSE.
    BROWNING HC; WHITE WD; GIBBS WE
    Tex Rep Biol Med; 1963; 21():511-27. PubMed ID: 14087152
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition by ergocornine and 2-Br-alpha-ergocryptin of spontaneous mammary tumor appearance in mice.
    Yanai R; Nagasawa H
    Experientia; 1971 Aug; 27(8):934-5. PubMed ID: 5147266
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of mammary cancer in mice without the mammary tumor agent by isografts of hypophyses.
    MUHLBOCK O; BOOT LM
    Cancer Res; 1959 May; 19(4):402-12. PubMed ID: 13652125
    [No Abstract]   [Full Text] [Related]  

  • 37. The direct effect of pituitary isografts on mammary gland development in the mouse.
    BARDIN CW; LIEBELT AG; LIEBELT RA
    Proc Soc Exp Biol Med; 1962; 110():716-8. PubMed ID: 13864941
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4).
    Matsuzawa A; Yamamoto T
    Cancer Res; 1977 Dec; 37(12):4408-15. PubMed ID: 922732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased incidence of mammary tumors in the female rat grafted with multiple pituitaries.
    Welsch CW; Jenkins TW; Meites J
    Cancer Res; 1970 Apr; 30(4):1024-9. PubMed ID: 5504344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.